Kui Cao
Impact in
-
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- Inflammasome and immune disorders
- Ubiquitin and proteasome pathways
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 11
- Epigenetics and DNA Methylation 3
- RNA Research and Splicing 3
-
- Ferroptosis and cancer prognosis 8
- Co-authors
- Jinhong Zhu (15 shared papers)Jianqun Ma (15 shared papers)Mingdong Liu (3 shared papers)Xiaodong Ling (7 shared papers)Ling Qi (1 shared paper)Junqing Gan (1 shared paper)Yuxian Bai (1 shared paper)Lisha Li (1 shared paper)
- Journals
- Cancer Immunology Immunotherapy (2 papers)Cell Death Discovery (1 paper)Aging (1 paper)Frontiers in Immunology (1 paper)Cancer Medicine (1 paper)
- Partner nations
- China
In The Last Decade
Kui Cao
19 papers receiving 305 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 103
- Molecular Biology 223
- Pulmonary and Respiratory Medicine 99
- Immunology 52
- Oncology 66
Countries citing papers authored by Kui Cao
This map shows the geographic impact of Kui Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Cao more than expected).
Fields of papers citing papers by Kui Cao
This network shows the impact of papers produced by Kui Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Cao. The network helps show where Kui Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Kui Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 87 | |
| 2 | 2021 | 54 | |
| 3 | 2023 | 27 | |
| 4 | 2021 | 18 | |
| 5 | 2021 | 15 | |
| 6 | 2021 | 14 | |
| 7 | 2022 | 14 | |
| 8 | 2021 | 12 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 10 | |
| 11 | 2021 | 8 | |
| 12 | 2024 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2025 | 3 | |
| 18 | 2024 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 0 |
About Kui Cao
Kui Cao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Epidemiology, having authored 20 papers that have together received 306 indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Ferroptosis and cancer prognosis (8 papers), Cancer-related molecular mechanisms research (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Epigenetics and DNA Methylation (3 papers), RNA Research and Splicing (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Cancer Research (103 citations), Molecular Biology (223 citations), Pulmonary and Respiratory Medicine (99 citations), Immunology (52 citations) and Oncology (66 citations). Kui Cao has collaborated with scholars based in China. Frequent co-authors include Jinhong Zhu, Jianqun Ma, Mingdong Liu, Xiaodong Ling, Ling Qi, Junqing Gan, Yuxian Bai, Lisha Li, Tongsen Zheng and Yiming Wu. Their work appears in journals such as Cancer Immunology Immunotherapy, Cell Death Discovery, Aging, Frontiers in Immunology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.